Head and Neck Maskless Immobilization Device in Immobilizing Patients With Head and Neck Cancer or Intracranial Tumors Undergoing Radiation Therapy
| Status: | Recruiting |
|---|---|
| Conditions: | Cancer, Cancer, Brain Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/29/2019 |
| Start Date: | February 24, 2017 |
| End Date: | February 2022 |
| Contact: | Voichita Bar Ad, MD |
| Email: | Voichita.Bar-Ad@jefferson.edu |
| Phone: | (215) 955-6702 |
A Single Institution Pilot Study Using a Head and Neck Maskless Immobilization Device (MID) for Patients With Head and Neck Cancer or Intracranial Tumors
This pilot clinical trial studies how well head and neck maskless immobilization device works
in immobilizing patients with head and neck cancers or intracranial tumors undergoing
radiation therapy. Maskless immobilization device may help to prevent movement of head during
radiation therapy and immobilize patients with the same accuracy and reliability as the
standard thermoplastic mask routinely used for patients receiving radiation therapy.
in immobilizing patients with head and neck cancers or intracranial tumors undergoing
radiation therapy. Maskless immobilization device may help to prevent movement of head during
radiation therapy and immobilize patients with the same accuracy and reliability as the
standard thermoplastic mask routinely used for patients receiving radiation therapy.
PRIMARY OBJECTIVES:
I. To assess the setup accuracy and reproducibility of the maskless immobilization device
(MID) in patients being treated for head and neck cancers or intracranial tumors who require
radiation therapy
SECONDARY OBJECTIVES:
I. To assess the patient comfort and quality of life with the MID compared to the
thermoplastic mask.
I. To assess the setup accuracy and reproducibility of the maskless immobilization device
(MID) in patients being treated for head and neck cancers or intracranial tumors who require
radiation therapy
SECONDARY OBJECTIVES:
I. To assess the patient comfort and quality of life with the MID compared to the
thermoplastic mask.
Inclusion Criteria:
- Patients being treated for head and neck cancers who require radiation therapy or
intracranial tumors, over a 2 to 7 week period of time
- Age ≥ 18 years old
- Subjects are capable of giving informed consent or have an acceptable surrogate
capable of giving consent on the subject's behalf
- Provide signed and dated informed consent form
Exclusion Criteria
- History of prior trauma or orthopedic surgery to the cervical vertebral column/spine,
which may interfere with the RT planning process
- Patient requires a neck brace for medical reasons
- Skull or bony defect in the area contacting the immobilization straps
- RT delivered by clinical setup only (no CT simulation)
We found this trial at
1
site
Philadelphia, Pennsylvania 19107
Phone: 215-955-6702
Click here to add this to my saved trials
